Evidence map›Paper›PMID 34185173›Full record

ArticleInternational journal of clinical oncology2021

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the Clinical Practice of Hereditary Colorectal Cancer.

Naohiro Tomita, Hideyuki Ishida, Kohji Tanakaya, Tatsuro Yamaguchi, Kensuke Kumamoto, Toshiaki Tanaka, Takao Hinoi, Yasuyuki Miyakura, Hirotoshi Hasegawa, Tetsuji Takayama and 16 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of clinical oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 101 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed, 4 pooled it
16.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 4 syntheses or guidelines pooled it, 154 citations in OpenAlex.

  1. Guideline
  2. Guideline
  3. Pooled it
  4. Guideline
  5. Trial
  6. Observational
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 20 institutions in 1 country.

Naohiro Tomita *Cancer Treatment Center, Toyonaka Municipal Hospital, 4-14-1, Shibahara, Toyonaka, Osaka, 560-8565, Japan. ntomita-home@maia.eonet.ne.jp.ORCID http://orcid.org/0000-0002-0963-1533
Hideyuki Ishida *Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Kohji TanakayaDepartment of Surgery, Iwakuni Clinical Center, Iwakuni, Japan.
Tatsuro YamaguchiDepartment of Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
Kensuke KumamotoDepartment of Gastroenterological Surgery, Kagawa University, Kagawa, Japan.
Toshiaki TanakaDepartment of Surgery, International Catholic Hospital, Tokyo, Japan.
Takao HinoiDepartment of Clinical and Molecular Genetics, Hiroshima University Hospital, Hiroshima, Japan.
Yasuyuki MiyakuraDepartment of Surgery, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
Hirotoshi HasegawaDepartment of Surgery, Tokyo Dental College Ichikawa General Hospital, Ichikawa, Japan.
Tetsuji TakayamaDepartment of Gastroenterology and Oncology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
Hideki IshikawaDepartment of Molecular-Targeting Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Takeshi NakajimaDepartment of Clinical Genetics, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Akiko ChinoDepartment of Gastroenterology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Hideki ShimodairaDivision of Medical Oncology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Akira HirasawaDepartment of Clinical Genomic Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Yoshiko NakayamaDepartment of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan.
Shigeki SekineDivision of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.
Kazuo TamuraDivision of Genetic Medicine, Master of Science, Graduate School of Science and Engineering Research, Kindai University, Higashiosaka, Japan.
Kiwamu AkagiDepartment of Molecular Diagnosis and Cancer Prevention, Saitama Cancer Center, Saitama, Japan.
Yuko KawasakiDivision of Cancer Nursing, College of Nursing Art and Science, University of Hyogo, Akashi, Japan.
Hirotoshi KobayashiDepartment of Surgery, Teikyo University School of Medicine, Mizonokuchi Hospital, Kawasaki, Japan.
Masami AraiClinical Genetics, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Michio ItabashiDepartment of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University, Tokyo, Japan.
Yojiro HashiguchiDepartment of Surgery, Teikyo University School of Medicine, Tokyo, Japan.
Kenichi SugiharaTokyo Medical and Dental University, Tokyo, Japan.
Japanese Society for Cancer of the Colon, Rectum
Japanese Foundation For Cancer Research · JPJichi Medical University · JPJuntendo University · JPKagawa University · JPKyoto Prefectural University of Medicine · JPSaitama Cancer Center · JPTokyo Medical and Dental University · JPToyonaka Municipal Hospital · JPIwakuni Medical Center · JPKindai University · JPSt. Luke's International Hospital · JPTeikyo University · JPTokyo Metropolitan Komagome Hospital · JPTokyo Women's Medical University · JPHiroshima University Hospital · JPOkayama University · JPShinshu University · JPSocial Insurance Saitama Chuo Hospital · JPTohoku Medical and Pharmaceutical University · JPTokushima University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hereditary colorectal cancer (HCRC) accounts for < 5% of all colorectal cancer cases. Some of the unique characteristics commonly encountered in HCRC cases include early age of onset, synchronous/metachronous cancer occurrence, and multiple cancers in other organs. These characteristics necessitate different management approaches, including diagnosis, treatment or surveillance, from sporadic colorectal cancer management. There are two representative HCRC, named familial adenomatous polyposis and Lynch syndrome. Other than these two HCRC syndromes, related disorders have also been reported. Several guidelines for hereditary disorders have already been published worldwide. In Japan, the first guideline for HCRC was prepared by the Japanese Society for Cancer of the Colon and Rectum (JSCCR), published in 2012 and revised in 2016. This revised version of the guideline was immediately translated into English and published in 2017. Since then, several new findings and novel disease concepts related to HCRC have been discovered. The currently diagnosed HCRC rate in daily clinical practice is relatively low; however, this is predicted to increase in the era of cancer genomic medicine, with the advancement of cancer multi-gene panel testing or whole genome testing, among others. Under these circumstances, the JSCCR guidelines 2020 for HCRC were prepared by consensus among members of the JSCCR HCRC Guideline Committee, based on a careful review of the evidence retrieved from literature searches, and considering the medical health insurance system and actual clinical practice settings in Japan. Herein, we present the English version of the JSCCR guidelines 2020 for HCRC.

Indexed as

Familial adenomatous polyposisGuidelinesHereditary colorectal cancerLynch syndrome

Identifiers

PMID34185173
PMCPMC8286959
OpenAlexW3177398479

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.